Cardiovascular Drug Reviews

Show Articles
Journal Properties
  • Language
    English
  • Number of Articles
    610
  • Abbreviation
    Cardiovasc Drug Rev
  • ISSN
    0897-5957
  • e-ISSN
    1527-3466
  • Main Publisher
    Neva Press, Inc.
  • Publisher
    Wiley
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Description
Cardiovascular Drug Reviews provides a comprehensive and in-depth analysis of pharmaceuticals used in treating cardiovascular diseases. It acts as a key resource for cardiologists, pharmacologists, and researchers interested in the latest advancements in cardiovascular pharmacology. This journal offers critical reviews and expert opinions on the mechanisms of action, clinical efficacy, and safety profiles of various cardiovascular drugs. Key topics covered include antiarrhythmics, antihypertensives, lipid-lowering agents, and antithrombotic therapies. The journal also explores emerging therapeutic targets and novel drug candidates for managing heart failure, coronary artery disease, and other cardiovascular conditions. Cardiovascular Drug Reviews serves as a vital resource for healthcare professionals seeking comprehensive knowledge and evidence-based insights into cardiovascular pharmacology. The journal bridges the gap between basic science and clinical practice, supporting the development and application of innovative treatments for cardiovascular diseases. Contributing to its enduring impact are the analyses it presents and supports regarding emerging heart related drugs.